Literature DB >> 7532838

Non-endotoxinic tumour necrosis factor-alpha-inducing factors in haemodialysis.

J L Mege1, P Brunet, C Capo, B Dussol, P Bongrand, Y Berland.   

Abstract

A transmembrane passage of endotoxins may account for the dysfunction of cytokine production which has been often reported in haemodialysis. We developed an assay based on the ability of patient serum to stimulate tumour necrosis factor alpha (TNF alpha) secretion in normal peripheral blood mononuclear cells. Three groups of subjects were investigated: normal controls (n = 14), patients with chronic renal failure, CRF (n = 15), and patients dialysed with polyacrylonitrile (n = 7), polysulphone (n = 8), and cellulose acetate (n = 7). Sera from dialysed patients displayed a significantly higher TNF alpha-inducing activity than those of controls and CRF patients. The ability of serum to elicit TNF alpha secretion was neither modified during the dialysis session nor influenced by the type of haemodialysis membrane. TNF alpha-inducing activity in serum was not inhibited by polymyxin B, known to impair endotoxin-dependent cell responses, thus suggesting that it was not related to circulating endotoxins. We conclude that non-endotoxinic factors are present in serum from dialysed patients and are able to induce cytokine secretion.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7532838

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  2 in total

1.  Circulating cytokine balance and activation markers of leucocytes in Q fever.

Authors:  C Capo; N Amirayan; E Ghigo; D Raoult; J Mege
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

Review 2.  Targeted complement inhibition as a promising strategy for preventing inflammatory complications in hemodialysis.

Authors:  Robert A DeAngelis; Edimara S Reis; Daniel Ricklin; John D Lambris
Journal:  Immunobiology       Date:  2012-11       Impact factor: 3.144

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.